GO
Loading...

What's Next For Pharma?

Wednesday, 16 May 2012 | 1:16 PM ET

Bristol-Myers' top selling blood thinner "Plavix" is going generic, reports CNBC's Seema Mody. Matt Cheslock, Virtu Financial, weighs in on how to trade the pharmaceuticals sector right now.